Simplify Logo

Full-Time

Profound Therapeutics: Head of Immunology

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Venture Capital

Senior, Expert

Boston, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. in Immunology/biology or a related field.
  • Minimum of 8-10 years of experience in immunology research.
  • Ability to work collaboratively in a multidisciplinary environment.
  • Strong statistical analysis and bioinformatics/genetics skills.
  • Strong analytical and problem-solving skills.
  • Excellent project management and organizational skills.
  • Excellent communication and leadership abilities.
Responsibilities
  • Lead and oversee ProFound’s immunology research and early development project portfolio.
  • Develop, implement and apply innovative immunological assays and techniques.
  • Design screening and assay strategies to characterize novel proteins and peptides in the immunology space.
  • Collaborate with cross-functional teams including biologists, protein engineers, and clinicians, including CROs.
  • Create and present research strategies and portfolio developments to internal and external stakeholders.
  • Stay updated with the latest clinical and pre-clinical advancements in immunology and related fields.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.